FDA
-
-
-
-
-
-
-
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
-
-
-
-
-
-
-
CVRx Reports Preliminary First Quarter 2026 Financial Results
-
-
-
-
-
-
-
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
-
-
-
-
-
-
-
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
-
-
-
-
-
-
-
CVRx Reports First Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
-
-
-
-
-
-
-
CVRx announces new CPT® Category I codes for Barostim
-
326,549 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

